Mycobacterium fortuitum Infection in Breast Implant and Rib Osteomyelitis: A Case Report and Review of Literature
Abstract
Abstract Breast implant–associated Mycobacterium fortuitum infections with presumed rib osteomyelitis are exceedingly rare, with fewer than 7 cases reported globally. We report the first documented case from Latin America, identified through systematic review of PubMed and SciELO databases. A 25-year-old woman with no predisposing comorbidities underwent mastopexy and breast augmentation with a retropectoral silicone implant. She developed a persistent left breast wound unresponsive to conventional treatment at an outside institution and was referred to our center ∼14 months postoperatively with a chronic fistula and rib exposure. A multidisciplinary approach (plastic surgery, orthopedic surgery, and infectious disease) was employed. Serial surgical debridement with vacuum-assisted closure therapy was performed. Cultures confirmed M. fortuitum sensitive to clarithromycin and doxycycline; combination therapy with clarithromycin and moxifloxacin was administered for 6 months. Wound closure was achieved with epigastric and thoracoabdominal pedicle flaps, followed by bilateral autologous fat grafting for breast reconstruction. At 8-year follow-up, the patient reported satisfaction with the aesthetic result. This case emphasizes the importance of maintaining clinical suspicion for nontuberculous mycobacterial infection in chronic nonhealing wounds following breast implant surgery, even in immunocompetent patients without identifiable risk factors. Level of Evidence: 5…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.